NCT00001736View on ClinicalTrials.gov

New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis

PHASE1CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

May 31, 1998

Study Completion Date

March 31, 2001

Conditions
Cystinosis
Interventions
DRUG

Cysteamine

Trial Locations (1)

20892

National Eye Institute (NEI), Bethesda

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH

NCT00001736 - New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis | Biotech Hunter | Biotech Hunter